Top

European Journal of Orthopaedic Surgery & Traumatology

Published in:

01-10-2019 | Magnetic Resonance Imaging | General Review • TUMORS - METASTASES

What’s new in management of bone metastases?

Authors: Costantino Errani, Alberto Bazzocchi, Paolo Spinnato, Giancarlo Facchini, Laura Campanacci, Giuseppe Rossi, Andreas F. Mavrogenis

Published in: European Journal of Orthopaedic Surgery & Traumatology | Issue 7/2019

Abstract

Metastases are the most common malignancy in bone. In patients with bone metastases, especially if a limited expected survival, the indications for surgical treatment are limited, immediate pain relief and improvement in the functional status are important, and complications of treatments are unwanted. Novel medical treatments can offer an effective palliative option in these patients. Advances in interventional radiology and surgery have led to the development of less invasive techniques with the aim to achieve the same clinical results with less surgical morbidity. These include embolization, electrochemotherapy, magnetic resonance imaging-guided high-intensity focused ultrasound, and thermal ablation. Less invasive techniques combine the advantages of less invasive procedures including decreased blood loss, earlier functional recovery and initiation of adjuvant medical therapies and seem to be both effective in pain relief and local tumor control.

Cheung FH (2014) The practicing orthopedic surgeon’s guide to managing long bone metastases. Orthop Clin North Am 45:109–119. https://doi.org/10.1016/j.ocl.2013.09.003 CrossRefPubMed

Weber KL, Randall RL, Grossman S, Parvizi J (2006) Management of lower-extremity bone metastasis. J Bone Joint Surg Am 88(Suppl 4):11–19. https://doi.org/10.2106/JBJS.F.00635 CrossRefPubMed

Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12:6243s–6249s. https://doi.org/10.1158/1078-0432.CCR-06-0931 CrossRefPubMed

Schulman KL, Kohles J (2007) Economic burden of metastatic bone disease in the U.S. Cancer 109:2334–2342. https://doi.org/10.1002/cncr.22678 CrossRefPubMed

Errani C, Mavrogenis AF, Cevolani L et al (2016) Treatment for long bone metastases based on a systematic literature review. Eur J Orthop Surg Traumatol Orthop Traumatol 27:205–211. https://doi.org/10.1007/s00590-016-1857-9 CrossRef

Ratasvuori M, Wedin R, Hansen BH et al (2014) Prognostic role of en-bloc resection and late onset of bone metastasis in patients with bone-seeking carcinomas of the kidney, breast, lung, and prostate: SSG study on 672 operated skeletal metastases. J Surg Oncol 110:360–365. https://doi.org/10.1002/jso.23654 CrossRefPubMed

Forsberg JA, Eberhardt J, Boland PJ et al (2011) Estimating survival in patients with operable skeletal metastases: an application of a bayesian belief network. PLoS ONE 6:e19956. https://doi.org/10.1371/journal.pone.0019956 CrossRefPubMedPubMedCentral

Zheng GZ, Chang B, Lin FX et al (2016) Meta-analysis comparing denosumab and zoledronic acid for treatment of bone metastases in patients with advanced solid tumours. Eur J Cancer Care (Engl) 26:e12541. https://doi.org/10.1111/ecc.12541 CrossRef

Henry DH, Costa L, Goldwasser F et al (2011) Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. J Clin Oncol 29:1125–1132. https://doi.org/10.1200/JCO.2010.31.3304 CrossRefPubMed

10.

Chen F, Pu F (2016) Safety of denosumab versus zoledronic acid in patients with bone metastases: a meta-analysis of randomized controlled trials. Oncol Res Treat 39:453–459. https://doi.org/10.1159/000447372 CrossRefPubMed

11.

Criscitiello C, Viale G, Gelao L et al (2015) Crosstalk between bone niche and immune system: osteoimmunology signaling as a potential target for cancer treatment. Cancer Treat Rev 41:61–68. https://doi.org/10.1016/j.ctrv.2014.12.001 CrossRefPubMed

12.

Rossi G, Mavrogenis AF, Casadei R et al (2013) Embolisation of bone metastases from renal cancer. Radiol Med (Torino) 118:291–302. https://doi.org/10.1007/s11547-012-0802-4 CrossRef

13.

Owen RJ (2010) Embolization of musculoskeletal bone tumors. Semin Intervent Radiol 27(2):111–123. https://doi.org/10.1055/s-0030-1253510 CrossRefPubMedPubMedCentral

14.

Luksanapruksa P, Buchowski JM, Tongsai S et al (2018) Systematic review and meta-analysis of effectiveness of preoperative embolization in surgery for metastatic spine disease. J Neurointervent Surg 10:596–601. https://doi.org/10.1136/neurintsurg-2017-013350 CrossRef

15.

Kim W, Han I, Jae HJ et al (2015) Preoperative embolization for bone metastasis from hepatocellular carcinoma. Orthopedics 38:e99–e105. https://doi.org/10.3928/01477447-20150204-56 CrossRefPubMed

16.

Pazionis TJC, Papanastassiou ID, Maybody M, Healey JH (2014) Embolization of hypervascular bone metastases reduces intraoperative blood loss: a case-control study. Clin Orthop 472:3179–3187. https://doi.org/10.1007/s11999-014-3734-3 CrossRefPubMed

17.

Kato S, Hozumi T, Takaki Y et al (2013) Optimal schedule of preoperative embolization for spinal metastasis surgery. Spine 38:1964–1969. https://doi.org/10.1097/BRS.0b013e3182a46576 CrossRefPubMed

18.

Facchini G, Di Tullio P, Battaglia M et al (2016) Palliative embolization for metastases of the spine. Eur J Orthop Surg Traumatol Orthop Traumatol 26:247–252. https://doi.org/10.1007/s00590-015-1726-y CrossRef

19.

Jiang C, Wang J, Wang Y et al (2016) Treatment outcome following transarterial chemoembolization in advanced bone and soft tissue sarcomas. Cardiovasc Intervent Radiol 39:1420–1428. https://doi.org/10.1007/s00270-016-1399-x CrossRefPubMed

20.

Rossi G, Mavrogenis AF, Rimondi E et al (2011) Selective embolization with N-butyl cyanoacrylate for metastatic bone disease. J Vasc Interv Radiol JVIR 22:462–470. https://doi.org/10.1016/j.jvir.2010.12.023 CrossRefPubMed

21.

Cazzato RL, Arrigoni F, Boatta E et al (2018) Percutaneous management of bone metastases: state of the art, interventional strategies and joint position statement of the Italian College of MSK Radiology (ICoMSKR) and the Italian College of Interventional Radiology (ICIR). Radiol Med Torino 124:34–49. https://doi.org/10.1007/s11547-018-0938-8 CrossRefPubMed

22.

Goetz MP, Callstrom MR, Charboneau JW et al (2004) Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol 22:300–306. https://doi.org/10.1200/JCO.2004.03.097 CrossRefPubMed

23.

Callstrom MR, Charboneau JW, Goetz MP et al (2002) Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radio-frequency ablation. Radiology 224:87–97. https://doi.org/10.1148/radiol.2241011613 CrossRefPubMed

24.

Seror O (2015) Ablative therapies: advantages and disadvantages of radiofrequency, cryotherapy, microwave and electroporation methods, or how to choose the right method for an individual patient? Diagn Interv Imaging 96:617–624. https://doi.org/10.1016/j.diii.2015.04.007 CrossRefPubMed

25.

Kurup AN, Callstrom MR (2010) Image-guided percutaneous ablation of bone and soft tissue tumors. Semin Interv Radiol 27:276–284. https://doi.org/10.1055/s-0030-1261786 CrossRef

26.

Dupuy DE, Liu D, Hartfeil D et al (2010) Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trial. Cancer 116:989–997. https://doi.org/10.1002/cncr.24837 CrossRefPubMedPubMedCentral

27.

Zhao W, Wang H, Hu J-H et al (2018) Palliative pain relief and safety of percutaneous radiofrequency ablation combined with cement injection for bone metastasis. Jpn J Clin Oncol 48:753–759. https://doi.org/10.1093/jjco/hyy090 CrossRefPubMed

28.

Wallace AN, Greenwood TJ, Jennings JW (2015) Radiofrequency ablation and vertebral augmentation for palliation of painful spinal metastases. J Neurooncol 124:111–118. https://doi.org/10.1007/s11060-015-1813-2 CrossRefPubMed

29.

Wallace AN, Tomasian A, Vaswani D et al (2016) Radiographic local control of spinal metastases with percutaneous radiofrequency ablation and vertebral augmentation. AJNR Am J Neuroradiol 37:759–765. https://doi.org/10.3174/ajnr.A4595 CrossRefPubMed

30.

Thacker PG, Callstrom MR, Curry TB et al (2011) Palliation of painful metastatic disease involving bone with imaging-guided treatment: comparison of patients’ immediate response to radiofrequency ablation and cryoablation. AJR Am J Roentgenol 197:510–515. https://doi.org/10.2214/AJR.10.6029 CrossRefPubMed

31.

Susa M, Kikuta K, Nakayama R et al (2016) CT guided cryoablation for locally recurrent or metastatic bone and soft tissue tumor: initial experience. BMC Cancer 16:798. https://doi.org/10.1186/s12885-016-2852-6 CrossRefPubMedPubMedCentral

32.

Barral M, Auperin A, Hakime A et al (2016) Percutaneous thermal ablation of breast cancer metastases in oligometastatic patients. Cardiovasc Intervent Radiol 39:885–893. https://doi.org/10.1007/s00270-016-1301-x CrossRefPubMed

33.

Madaelil TP, Wallace AN, Jennings JW (2016) Radiofrequency ablation alone or in combination with cementoplasty for local control and pain palliation of sacral metastases: preliminary results in 11 patients. Skeletal Radiol 45:1213–1219. https://doi.org/10.1007/s00256-016-2404-9 CrossRefPubMed

34.

Cazzato RL, Auloge P, De Marini P et al (2018) Percutaneous image-guided ablation of bone metastases: local tumor control in oligometastatic patients. Int J Hyperth 35:493–499. https://doi.org/10.1080/02656736.2018.1508760 CrossRef

35.

Bang HJ, Littrup PJ, Currier BP et al (2012) Percutaneous cryoablation of metastatic lesions from non-small-cell lung carcinoma: initial survival, local control, and cost observations. J Vasc Interv Radiol JVIR 23:761–769. https://doi.org/10.1016/j.jvir.2012.02.013 CrossRefPubMed

36.

Callstrom MR, Charboneau JW, Goetz MP et al (2006) Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problem. Skeletal Radiol 35:1–15. https://doi.org/10.1007/s00256-005-0003-2 CrossRefPubMed

37.

Bazzocchi A, Napoli A, Sacconi B et al (2016) MRI-guided focused ultrasound surgery in musculoskeletal diseases: the hot topics. Br J Radiol 89:20150358. https://doi.org/10.1259/bjr.20150358 CrossRefPubMed

38.

Liberman B, Gianfelice D, Inbar Y et al (2009) Pain palliation in patients with bone metastases using MR-guided focused ultrasound surgery: a multicenter study. Ann Surg Oncol 16:140–146. https://doi.org/10.1245/s10434-008-0011-2 CrossRefPubMed

39.

Napoli A, Anzidei M, Marincola BC et al (2013) Primary pain palliation and local tumor control in bone metastases treated with magnetic resonance-guided focused ultrasound. Invest Radiol 48:351–358. https://doi.org/10.1097/RLI.0b013e318285bbab CrossRefPubMed

40.

Hurwitz MD, Ghanouni P, Kanaev SV et al (2014) Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: phase III trial results. J Natl Cancer Inst. https://doi.org/10.1093/jnci/dju082 CrossRefPubMedPubMedCentral

41.

Lee H-L, Kuo C-C, Tsai J-T et al (2017) Magnetic resonance-guided focused ultrasound versus conventional radiation therapy for painful bone metastasis: a matched-pair study. J Bone Joint Surg Am 99:1572–1578. https://doi.org/10.2106/JBJS.16.01248 CrossRefPubMed

42.

Huisman M, ter Haar G, Napoli A et al (2015) International consensus on use of focused ultrasound for painful bone metastases: current status and future directions. Int J Hyperth 31:251–259. https://doi.org/10.3109/02656736.2014.995237 CrossRef

43.

Rodrigues DB, Stauffer PR, Vrba D, Hurwitz MD (2015) Focused ultrasound for treatment of bone tumours. Int J Hyperth 31:260–271. https://doi.org/10.3109/02656736.2015.1006690 CrossRef

44.

Mir LM, Belehradek M, Domenge C et al (1991) Electrochemotherapy, a new antitumor treatment: first clinical trial. C R Acad Sci III 313:613–618PubMed

45.

Belehradek M, Domenge C, Luboinski B et al (1993) Electrochemotherapy, a new antitumor treatment. First clinical phase I–II trial. Cancer 72:3694–3700CrossRef

46.

Colombo GL, Matteo SD, Mir LM (2008) Cost-effectiveness analysis of electrochemotherapy with the Cliniporatortrade mark vs other methods for the control and treatment of cutaneous and subcutaneous tumors. Ther Clin Risk Manag 4:541–548CrossRef

47.

Kotnik T, Pucihar G, Miklavcic D (2010) Induced transmembrane voltage and its correlation with electroporation-mediated molecular transport. J Membr Biol 236:3–13. https://doi.org/10.1007/s00232-010-9279-9 CrossRefPubMed

48.

Li W, Fan Q, Ji Z et al (2011) The effects of irreversible electroporation (IRE) on nerves. PLoS ONE 6:e18831. https://doi.org/10.1371/journal.pone.0018831 CrossRefPubMedPubMedCentral

49.

Mali B, Jarm T, Corovic S et al (2008) The effect of electroporation pulses on functioning of the heart. Med Biol Eng Comput 46:745–757. https://doi.org/10.1007/s11517-008-0346-7 CrossRefPubMedPubMedCentral

50.

Maor E, Ivorra A, Leor J, Rubinsky B (2007) The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat 6:307–312. https://doi.org/10.1177/153303460700600407 CrossRefPubMed

51.

Horiuchi A, Nikaido T, Mitsushita J et al (2000) Enhancement of antitumor effect of bleomycin by low-voltage in vivo electroporation: a study of human uterine leiomyosarcomas in nude mice. Int J Cancer 88:640–644CrossRef

52.

Fini M, Tschon M, Ronchetti M et al (2010) Ablation of bone cells by electroporation. J Bone Joint Surg Br 92:1614–1620. https://doi.org/10.1302/0301-620X.92B11.24664 CrossRefPubMed

53.

Miklavcic D, Beravs K, Semrov D et al (1998) The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J 74:2152–2158. https://doi.org/10.1016/S0006-3495(98)77924-X CrossRefPubMedPubMedCentral

54.

Miklavcic D, Snoj M, Zupanic A et al (2010) Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy. Biomed Eng Online 9:10. https://doi.org/10.1186/1475-925X-9-10 CrossRefPubMedPubMedCentral

55.

Bianchi G, Campanacci L, Ronchetti M, Donati D (2016) Electrochemotherapy in the treatment of bone metastases: a phase II trial. World J Surg 40:3088–3094. https://doi.org/10.1007/s00268-016-3627-6 CrossRefPubMedPubMedCentral

56.

Gasbarrini A, Campos WK, Campanacci L, Boriani S (2015) Electrochemotherapy to metastatic spinal melanoma: A novel treatment of spinal metastasis? Spine 40:E1340–E1346. https://doi.org/10.1097/BRS.0000000000001125 CrossRefPubMed

57.

Nathan SS, Healey JH, Mellano D et al (2005) Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care. J Clin Oncol 23:6072–6082. https://doi.org/10.1200/JCO.2005.08.104 CrossRefPubMed

58.

Ruggieri P, Mavrogenis AF, Casadei R, Errani C, Angelini A, Calabrò T, Pala E, Mercuri M (2010) Protocol of surgical treatment of long bone pathological fractures. Injury 41(11):1161–1167. https://doi.org/10.1016/j.injury.2010.09.018 CrossRefPubMed

Title: What’s new in management of bone metastases?
Authors: Costantino Errani
Alberto Bazzocchi
Paolo Spinnato
Giancarlo Facchini
Laura Campanacci
Giuseppe Rossi
Andreas F. Mavrogenis
Publication date: 01-10-2019
Publisher: Springer Paris
Keywords: Magnetic Resonance Imaging
Ultrasound
Magnetic Resonance Imaging
Metastasis
Interventional Radiology
Ultrasound
Bone Metastasis
Denosumab
Denosumab
Zoledronic Acid
Published in: European Journal of Orthopaedic Surgery & Traumatology / Issue 7/2019
Print ISSN: 1633-8065
Electronic ISSN: 1432-1068
DOI: https://doi.org/10.1007/s00590-019-02446-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

What’s new in management of bone metastases?

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2019

Survival and functional outcome of revision total knee arthroplasty with a total stabilizer knee system: minimum 5 years of follow-up

Correction to: Arthroscopic fixation of ACL avulsion fracture in the Saint Paul Hospital: a review of treatment outcomes

Comparison of the AOSpine subaxial cervical spine injury classification system and the Allen classification

Distal biceps section and reinsertion for chronic distal biceps tendinopathy

Edgar N. Weaver, Jr.: Surgical care of the painful degenerative lumbar spine: evaluation, decision-making, techniques

Fast and slow myosin as markers of muscle regeneration in mangled extremities: a pilot study